Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Soon after KJ Muldoon was born in August 2024, he was lethargic and wouldn’t eat. His worried doctors realized his ammonia levels were scarily high. Further tests showed the infant had a rare metabolic disorder—the kind of diagnosis that’s often a death …